
- Volume 0 0
Intravenous Meds Improve Kids'Asthma Episodes
An intravenous infusion of magnesium sulphate along with conventional medications gives an additional benefit for children whorequire an emergency room visit because of a severe asthma attack. Looking at clinical trials involving 182 children, researchers inHong Kong analyzed the effects of intravenous magnesium sulphate with or without inhaled beta-2-agonist bronchodilators and oralsteroid drugs.
The goal of the study was to determine if the treatment prevented the children from being hospitalized. The researchers also sawa major improvement with magnesium treatment in short-term lung function tests and symptom scores. "Intravenous magnesium sulphateis likely to be effective in avoiding hospitalization and improving bronchoconstriction and clinical symptoms of moderate-tosevereacute asthma in children, when added to standard therapies of inhaled bronchodilators and systemic steroids,"concluded theresearchers in the Archives of Disease in Childhood (January 2005).
Articles in this issue
over 20 years ago
Heart Patients Get More Appropriate Rx Treatment from Cardiologistsover 20 years ago
Surgeon General Report Blasts Rx Drug Importing Practicesover 20 years ago
Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDAover 20 years ago
Expo Focuses on Caregiver Needsover 20 years ago
Early-Month Rx Fatalities Linked to Overworked Pharmacistsover 20 years ago
Feds Report Rx Expenditures Rose More Slowly in 2004over 20 years ago
Rx.com Offers Alternative to PBM Mail Orderover 20 years ago
Americans Rate US Health Care as Poorover 20 years ago
Pharmacy Security Combo Pack Now Availableover 20 years ago
IOM Advocates Tougher Supplement StandardsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.